Kazuo Tomita

Kagoshima, 8908544, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.

The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.

Journal: Neurochemical research

Published: May 08, 2026

Daisaikoto restores mitochondrial function and suppresses inflammation induced by periodontal bacteria-derived lipopolysaccharides.

Daisaikoto restores mitochondrial function and suppresses inflammation induced by periodontal bacteria-derived lipopolysaccharides.

Journal: Journal of dental sciences

Published: January 03, 2026

Wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, suppresses methamphetamine-induced stereotypy and hyperlocomotion in mice.

Wortmannin, a potent phosphatidylinositol 3-kinase inhibitor, suppresses methamphetamine-induced stereotypy and hyperlocomotion in mice.

Journal: Behavioural pharmacology

Published: November 20, 2025

The radioresistance of clinically relevant radioresistant cell-derived tumors is determined by the cancer cells themselves, rather than by the surrounding stromal cells.

The radioresistance of clinically relevant radioresistant cell-derived tumors is determined by the cancer cells themselves, rather than by the surrounding stromal cells.

Journal: Journal of dental sciences

Published: June 20, 2025

Amoxicillin, a β-lactam antibiotic, enhances cisplatin sensitivity in cancer cells affecting mitochondria.

Amoxicillin, a β-lactam antibiotic, enhances cisplatin sensitivity in cancer cells affecting mitochondria.

Journal: Biochemical and biophysical research communications

Published: April 07, 2025

Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice.

Pretreatment with LY2090314, a potent glycogen synthase kinase-3 inhibitor, suppresses methamphetamine-induced stereotyped behavior but not hyperlocomotion in mice.

Journal: Behavioural pharmacology

Published: April 04, 2025

Unlocking the potential of mitochondrial transplantation: overcoming challenges and paving the way for routine therapeutic application.

Unlocking the potential of mitochondrial transplantation: overcoming challenges and paving the way for routine therapeutic application.

Journal: Cytotechnology

Published: March 29, 2025

Protein phosphatase 2A inhibitors: a possible pharmacotherapy for benzodiazepine dependence.

Protein phosphatase 2A inhibitors: a possible pharmacotherapy for benzodiazepine dependence.

Journal: The Journal of pharmacy and pharmacology

Published: July 24, 2024

Opioid receptor antagonists reduce motivated wheel-running behavior in mice.

Opioid receptor antagonists reduce motivated wheel-running behavior in mice.

Journal: Behavioural pharmacology

Published: March 07, 2024

Therapeutic potential for KCC2-targeted neurological diseases.

Therapeutic potential for KCC2-targeted neurological diseases.

Journal: The Japanese dental science review

Published: July 25, 2023

Kamishoyosan and Kamikihito protect against decreased KCC2 expression induced by the P. gingivalis lipopolysaccharide treatment in PC-12 cells and improve behavioral abnormalities in male mice.

Kamishoyosan and Kamikihito protect against decreased KCC2 expression induced by the P. gingivalis lipopolysaccharide treatment in PC-12 cells and improve behavioral abnormalities in male mice.

Journal: Heliyon

Published: May 10, 2023

Comparative data on emotional (psychotic) aggressive biting behavior in mice of ddY strain measured by using two devices; Aggressive response meter and powerlab-compatible type aggressive response meter.

Comparative data on emotional (psychotic) aggressive biting behavior in mice of ddY strain measured by using two devices; Aggressive response meter and powerlab-compatible type aggressive response meter.

Journal: Data in brief

Published: April 16, 2023

Showing 1-12 of 53

Last Updated: 09/26/2026